Can biomarkers aid the stratification of individuals with mood disorders for cognitive remediation interventions?
Katie M Douglas, Rebecca Strawbridge, Kamilla W Miskowiak
Author Information
- Katie M Douglas: Department of Psychological Medicine, University of Otago, Christchurch, New Zealand. ORCID
- Rebecca Strawbridge: Department of Psychological Medicine, King's College London, London, UK. ORCID
- Kamilla W Miskowiak: Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
No abstract text available.
- Ott CV, Vinberg M, Kessing LV, Bowie CR, Forman JL, Miskowiak KW. Effect of action-based cognitive remediation on cognitive impairment in patients with remitted bipolar disorder: a randomized controlled trial. Bipolar Disord. 2020;23:487-499.
- Strawbridge R, Tsapekos D, Hodsoll J, et al. Cognitive remediation therapy for patients with bipolar disorder: A randomised proof-of-concept trial. Bipolar Disord. 2021;23:196-208.
- Douglas KM, Groves S, Crowe MT, et al. A randomised controlled trial of psychotherapy and cognitive remediation to target cognition in mood disorders. Acta Psychiatr Scand. 2022;145:278-292.
- Miskowiak KW, Moller AB, Ott CV. Neuronal and cognitive predictors of improved executive function following action-based cognitive remediation in patients with bipolar disorder. Eur Neuropsychopharmacol. 2021;47:1-10.
- Tsapekos D, Strawbridge R, Cella M, Wykes T, Young AH. Towards personalizing cognitive remediation therapy: Examining moderators of response for euthymic people with bipolar disorder. Behav Res Ther. 2022;151:104054.
Biomarkers
Bipolar Disorder
Cognitive Remediation
Humans
Mood Disorders
